Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseRestructuring CostsRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Acadia Healthcare Company (ACHC) EBIT (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed EBIT for 17 consecutive years, with -$120.1 million as the latest value for Q1 2026.

  • For Q1 2026, EBIT fell 707.55% year-over-year to -$120.1 million; the TTM value through Mar 2026 reached -$1.4 billion, down 4590.71%, while the annual FY2025 figure was -$223.8 million, 126.32% down from the prior year.
  • EBIT hit -$120.1 million in Q1 2026 for Acadia Healthcare Company, up from -$1.2 billion in the prior quarter.
  • Across five years, EBIT topped out at $78.6 million in Q2 2024 and bottomed at -$1.2 billion in Q4 2025.
  • Average EBIT over 5 years is -$121.0 million, with a median of -$13.6 million recorded in 2024.
  • Year-over-year, EBIT tumbled 3978.96% in 2023 and then surged 15070.27% in 2024.
  • Acadia Healthcare Company's EBIT stood at -$186.9 million in 2022, then dropped by 22.85% to -$229.6 million in 2023, then skyrocketed by 65.21% to -$79.9 million in 2024, then crashed by 1402.45% to -$1.2 billion in 2025, then soared by 89.99% to -$120.1 million in 2026.
  • According to Business Quant data, EBIT over the past three periods came in at -$120.1 million, -$1.2 billion, and $9.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.